VPT:CC - Ventripoint to Issue Shares for Payment of Debenture Interest
(TheNewswire)
Toronto, Ontario – TheNewswire - June 30, 2025 –Ventripoint Diagnostics Ltd. (“ Ventripoint ” or the“ Corporation ”, ( TSXV:VPT) announces it will satisfy debenture interestpayment obligations with the issuance of common shares, subject to TSXVenture Exchange (“ TSXV ”) approval. The Corporation will issuean aggregate of 564,473 common shares (“ Shares ”) for thepayment of an aggregate of $76,203.59 of interest owing on certainoutstanding Convertible Debentures issued by the Corporation on May10, 2024, September 20, 2024 and December 16, 2024. The ConvertibleDebentures bear interest at the rate of 10% per annum, payable every 6months. The Shares will be issued at a deemed price of $0.135, subjectto the approval of TSXV and are subject to a hold period of 4 monthsand one day. The issuance of the Shares will not create a controlperson of the Corporation.
About Ventripoint DiagnosticsLtd.
Ventripoint has become anindustry leader in the application of AI (Artificial Intelligence) toechocardiography. Ventripoint's VMS products are powered by itsproprietary knowledge-based reconstruction technology, which is theresult of a decade of development and provides accurate volumetriccardiac measurements equivalent to MRI. This affordable, gold-standardalternative allows cardiologists greater confidence in the managementof their patients. Providing better care to patients serves as aspringboard and basic standard for all of Ventripoint's products thatguide our future developments. In addition, VMS+ is versatile and canbe used with all ultrasound systems from any vendor supported byregulatory market approvals in the U.S., Europe and Canada.
For further information, pleasecontact:
Hugh MacNaught
hmacnaught@ventripoint.com
604-671-4201
Neither the TSX Venture Exchange norits Regulation Services Provider (as that term is defined in thepolicies of the TSX Venture Exchange) accepts responsibility for theadequacy or accuracy of this news release.
Forward Looking Statements
This news release contains forward-looking statementsand forward-looking information within the meaning of applicablesecurities laws. The use of any of the words "expect","anticipate", "continue", "estimate","objective", "ongoing", "may","will", "project", "should","believe", "plans", "intends'' and similarexpressions are intended to identify forward-looking information orstatements. The forward-looking statements and information are basedon certain key expectations and assumptions made by the Corporation.Although the Corporation believes that the expectations andassumptions on which such forward-looking statements and informationare based are reasonable, undue reliance should not be placed on theforward-looking statements and information because the Corporation cangive no assurance that they will prove to be correct.
Since forward-looking statements and informationaddress future events and conditions, by their very nature theyinvolve inherent risks and uncertainties. Actual results could differ materially from those currentlyanticipated due to a number of factors and risks. Factors which couldmaterially affect such forward-looking information are described inthe risk factors in the Corporation's most recent annual management'sdiscussion and analysis that is available on the Corporation's profileon SEDAR+ at www.sedarplus.ca. Readersare cautioned that the foregoing list of factors is not exhaustive.The forward-looking statements included in this news release areexpressly qualified by this cautionary statement. The forward-lookingstatements and information contained in this news release are made asof the date hereof and the Corporation undertakes no obligation toupdate publicly or revise any forward-looking statements orinformation, whether as a result of new information, future events orotherwise, unless so required by applicable securities laws.
Copyright (c) 2025 TheNewswire - All rights reserved.